Sub menu

 
 

(Approval lapsed) Famotidine tablets USP 20mg (BluePoint, USA)

Section 19A approved medicine
(Approval lapsed) Famotidine tablets USP 20mg (BluePoint, USA)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
AUSFAM 20 famotidine 20mg tablet blister pack - ARTG 93788
Indication(s)
  • Duodenal ulcer
  • Benign gastric ulcer
  • Zollinger-Ellison syndrome
  • Prevention of relapses of duodenal ulceration
  • Short-term (no more than 12 weeks) symptomatic relief of gastroesophageal reflux not responsive to conservative measures
  • Healing of oesophageal erosion or ulceration associated with gastroesophageal reflux disease
  • Prevention of relapses of symptoms and erosions or ulcerations associated with gastroesophageal reflux disease
Related medicines shortage notifications
https://apps.tga.gov.au/Prod/msi/Search/Tradename//93788
Images
Picture of Famotidine tablets USP 20mg

Help us improve the Therapeutic Goods Administration site